Trademark: 79207593
Word
VIASKIN
Status Date
Tuesday, July 3, 2018
Registration Number
5505343
Registration Date
Tuesday, July 3, 2018
Filing Date
Thursday, December 1, 2016
Published for Opposition
Tuesday, April 17, 2018
41 Education services, namely, providing training in the form of classes and seminars in the field of immunotherapy; organization and conducting of educational colloquiums, educational conferences and educational conventions in the field of immunotherapy; organization and conducting of non-virtual educational forums in the field of immunotherapy; provision of non-downloadable videos in the field of immunotherapy online; electronic desktop publishing; provision of non-downloadable online electronic publications; organization of exhibitions for educational purposes
9 Data processing equipment, namely computers; Laboratory instrument for the detection of allergens for research use; downloadable computer software application for providing information regarding immunotherapy; interfaces for computers; downloadable electronic publications in the nature of practical sheets in the field of immunotherapy
16 Printed publications, namely, magazines in the field of immunotherapy; posters; pamphlets in the field of immunotherapy; printed informational fliers and leaflets featuring information regarding immunotherapy; newspapers; printed matter in the nature of manual handbooks in the field of immunotherapy; booklets in the field of immunotherapy; magazine journals featuring information about immunotherapy; printed instructional or teaching material in the field of immunotherapy excluding apparatus
44 Medical services in the nature of applying a method for desensitizing by immunotherapy; medical consultancy in the field of desensitization to combat allergies; health counselling services; health care services for treating immunotherapy
42 Scientific research services for medical purposes in the field of immunotherapy; research in the field of immunotherapy; scientific research in the field of processing and treatment of allergies; scientific research in the nature of discovery and development of allergens; design of methods for the treatment of allergy-causing by the combination of immune cells from the skin; research and development of new products for others
May 18, 2017
Sn Assigned For Sect 66a Appl From Ib
Oct 9, 2017
Correspondence Received In Law Office
May 22, 2017
New Application Office Supplied Data Entered
May 22, 2017
Assigned To Examiner
May 24, 2017
Non-Final Action Written
May 25, 2017
Non-Final Action (Ib Refusal) Prepared For Review
May 26, 2017
Application Filing Receipt Mailed
Jun 7, 2017
Refusal Processed By Mpu
Jun 7, 2017
Non-Final Action Mailed - Refusal Sent To Ib
Jun 24, 2017
Refusal Processed By Ib
Oct 9, 2017
Teas Response To Office Action Received
Oct 9, 2017
Teas/Email Correspondence Entered
Nov 2, 2017
Non-Final Action Written
Mar 10, 2018
Approved For Pub - Principal Register
Oct 20, 2017
Examiners Amendment -Written
Oct 20, 2017
Examiner's Amendment Entered
Oct 23, 2017
Examiners Amendment Mailed
Nov 3, 2017
Non-Final Action Mailed
Mar 1, 2018
Teas Response To Office Action Received
Mar 1, 2018
Correspondence Received In Law Office
Mar 1, 2018
Teas/Email Correspondence Entered
Oct 26, 2018
Final Decision Transaction Processed By Ib
Mar 28, 2018
Notice Of Publication
Mar 28, 2018
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
Mar 28, 2018
Notification Of Possible Opposition Sent To Ib
Apr 13, 2018
Notification Processed By Ib
Apr 17, 2018
Published For Opposition
Jul 3, 2018
Registered-Principal Register
Oct 3, 2018
Final Disposition Notice Created, To Be Sent To Ib
Oct 5, 2018
Final Disposition Processed
Oct 5, 2018
Final Disposition Notice Sent To Ib
Nov 1, 2021
New Representative At Ib Received
Jun 15, 2024
New Representative At Ib Received
Jul 13, 2024
Change Of Name/Address Rec'd From Ib
Trademark Alertz updated from USPTO on 2030-01-24
